Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

被引：0
|
作者：
Cliff Molife
Katherine B. Winfree
Hollie Bailey
Yulia D’yachkova
Cameron Forshaw
Sangmi Kim
Kaisa-Leena Taipale
Tarun Puri
机构：
[1] Eli Lilly and Company,Value, Evidence, and Outcomes
[2] Lilly Corporate Center,Oncology
[3] Adelphi Real World,Lilly International Medical Affairs Oncology
[4] Statistics,undefined
[5] Eli Lilly and Company,undefined
[6] Global Patient Safety-Pharmacoepidemiology,undefined
[7] Eli Lilly and Company,undefined
[8] Value,undefined
[9] Evidence,undefined
[10] and Outcomes-International,undefined
[11] Eli Lilly and Company,undefined
[12] Eli Lilly and Company,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Advanced non-small cell lung cancer; Disease Specific Programme™; mutation; Patient-reported outcomes; Point-in-time; Real-world; Survey; Treatment patterns;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3135 / 3168
页数：33
相关论文
共 50 条
  • [21] Clinical characteristics, real-world treatment patterns, and clinical outcomes among patients with previously treated metastatic or unresectable EGFR-mutated non-small cell lung cancer in the United States
    Patel, Jyoti D.
    Meng, Jie
    Phani, Sudarshan
    Crowley, Aaron
    Zhou, Summera
    Salas, Maribel
    Tanaka, Yoko
    Le, Hoa
    Anderson, Jeffrey
    Reckamp, Karen L.
    CANCER RESEARCH, 2023, 83 (07)
  • [22] Real-world treatment patterns and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced non-small cell lung cancer: Results from a large retrospective study (REFLECT)
    Pluzanski, A.
    Donev, I. Shterev
    Gafton, B.
    Janzic, U.
    Vidovic, D.
    Lupu, R.
    Teodorescu, G.
    Ciuleanu, T-E.
    ANNALS OF ONCOLOGY, 2021, 32 : S973 - S974
  • [23] Real-world disease characteristics and treatment patterns in patients with advanced non-small cell lung cancer and EGFR in Brazil and Taiwan
    Bailey, H.
    Burlison, H.
    Chandrasekar, S.
    Wong, C. H.
    Forshaw, C.
    Duncan, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S58 - S58
  • [24] Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States
    Enewold, Lindsey
    Thomas, Anish
    PLOS ONE, 2016, 11 (06):
  • [25] Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S319 - S319
  • [26] Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer
    Zhang, Xiaojuan
    Zhang, Mina
    Du, Xinyang
    Zhang, Guowei
    Niu, Yuanyuan
    Wei, Chunhua
    Guo, Lanwei
    Shi, Chao
    Liu, Hangfan
    Wang, Huijuan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] EGFR Exon 18 Mutations in Advanced Non-Small Cell Lung Cancer: A Real-World Study on Diverse Treatment Patterns and Clinical Outcomes
    Xu, Haiyan
    Yang, Guangjian
    Li, Weihua
    Li, Junling
    Hao, Xuezhi
    Xing, Puyuan
    Yang, Yaning
    Wang, Yan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] NEUROLOGICAL EVOLUTION OF A PATIENT WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCER
    Ianza, A.
    Dicorato, A.
    Guglielmi, A.
    Orlando, V.
    Furlanis, G.
    Curro, F.
    CHEST, 2022, 161 (06) : 333A - 333A
  • [29] Optimizing Treatment Strategies for Egfr-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights
    Thomas, Quentin Dominique
    Girard, Nicolas
    Bosquet, Lise
    Cavaillon, Sarah
    Filleron, Thomas
    Eltaief, Siham
    Chouaid, Christos
    Lena, Herve
    Debieuvre, Didier
    Perol, Maurice
    Quantin, Xavier
    CANCERS, 2024, 16 (21)
  • [30] Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer
    Di Marino, Pietro
    Chiapperino, Cosima
    Primavera, Francesca Chiara
    Martino, Maria Teresa
    Brocco, Davide
    Carella, Consiglia
    Grassadonia, Antonino
    Tinari, Nicola
    De Tursi, Michele
    ONCOTARGETS AND THERAPY, 2022, 15 : 407 - 410
12345